337 related articles for article (PubMed ID: 25005182)
1. Hydrogen sulfide and endothelial dysfunction: relationship with nitric oxide.
Altaany Z; Moccia F; Munaron L; Mancardi D; Wang R
Curr Med Chem; 2014; 21(32):3646-61. PubMed ID: 25005182
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen sulfide improves intestinal recovery following ischemia by endothelial nitric oxide-dependent mechanisms.
Jensen AR; Drucker NA; Khaneki S; Ferkowicz MJ; Markel TA
Am J Physiol Gastrointest Liver Physiol; 2017 May; 312(5):G450-G456. PubMed ID: 28280145
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen sulfide and endothelium-dependent vasorelaxation.
Bełtowski J; Jamroz-Wiśniewska A
Molecules; 2014 Dec; 19(12):21183-99. PubMed ID: 25521118
[TBL] [Abstract][Full Text] [Related]
4. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis.
Xu S; Liu Z; Liu P
Int J Cardiol; 2014 Mar; 172(2):313-7. PubMed ID: 24491853
[TBL] [Abstract][Full Text] [Related]
5. Role of Endothelial Dysfunction in Cardiovascular Diseases: The Link Between Inflammation and Hydrogen Sulfide.
Sun HJ; Wu ZY; Nie XW; Bian JS
Front Pharmacol; 2019; 10():1568. PubMed ID: 32038245
[TBL] [Abstract][Full Text] [Related]
6. Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
Donnarumma E; Ali MJ; Rushing AM; Scarborough AL; Bradley JM; Organ CL; Islam KN; Polhemus DJ; Evangelista S; Cirino G; Jenkins JS; Patel RA; Lefer DJ; Goodchild TT
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381758
[TBL] [Abstract][Full Text] [Related]
7. Novel Angiogenic Activity and Molecular Mechanisms of ZYZ-803, a Slow-Releasing Hydrogen Sulfide-Nitric Oxide Hybrid Molecule.
Hu Q; Wu D; Ma F; Yang S; Tan B; Xin H; Gu X; Chen X; Chen S; Mao Y; Zhu YZ
Antioxid Redox Signal; 2016 Sep; 25(8):498-514. PubMed ID: 27174595
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen sulfide inhibits development of atherosclerosis through up-regulating protein S-nitrosylation.
Lin Y; Chen Y; Zhu N; Zhao S; Fan J; Liu E
Biomed Pharmacother; 2016 Oct; 83():466-476. PubMed ID: 27427853
[TBL] [Abstract][Full Text] [Related]
9. Endogenous hydrogen sulfide-mediated MAPK inhibition preserves endothelial function through TXNIP signaling.
Tian D; Dong J; Jin S; Teng X; Wu Y
Free Radic Biol Med; 2017 Sep; 110():291-299. PubMed ID: 28669627
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide and the pathogenesis of atherosclerosis.
Mani S; Untereiner A; Wu L; Wang R
Antioxid Redox Signal; 2014 Feb; 20(5):805-17. PubMed ID: 23582095
[TBL] [Abstract][Full Text] [Related]
11. Endothelium as a Source and Target of H
Ciccone V; Genah S; Morbidelli L
Antioxidants (Basel); 2021 Mar; 10(3):. PubMed ID: 33808872
[TBL] [Abstract][Full Text] [Related]
12. The role of eNOS on the compensatory regulation of vascular tonus by H
Ertuna E; Loot AE; Fleming I; Yetik-Anacak G
Nitric Oxide; 2017 Sep; 69():45-50. PubMed ID: 28414104
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-dependent endothelial function and cardiovascular disease.
Desjardins F; Balligand JL
Acta Clin Belg; 2006; 61(6):326-34. PubMed ID: 17323842
[TBL] [Abstract][Full Text] [Related]
14. H
Monti M; Terzuoli E; Ziche M; Morbidelli L
Pharmacol Res; 2016 Nov; 113(Pt A):426-437. PubMed ID: 27650753
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide donors: Therapeutic potential in anti-atherosclerosis.
Zhang H; Bai Z; Zhu L; Liang Y; Fan X; Li J; Wen H; Shi T; Zhao Q; Wang Z
Eur J Med Chem; 2020 Nov; 205():112665. PubMed ID: 32795766
[TBL] [Abstract][Full Text] [Related]
16. Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease.
Polhemus DJ; Lefer DJ
Circ Res; 2014 Feb; 114(4):730-7. PubMed ID: 24526678
[TBL] [Abstract][Full Text] [Related]
17. [Molecular Mechanisms of Action of Gas Transmitters NO, CO and H2S in Smooth Muscle Cells and Effect of NO-generating Compounds (Nitrates and Nitrites) on Average Life Expectancy].
Gusakova SV; Smagliy LV; Birulina YG; Kovalev IV; Nosarev V; Petrova IV; Reutov VP
Usp Fiziol Nauk; 2017; 48(1):24-52. PubMed ID: 29283238
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide improves endothelial dysfunction in hypertension by activating peroxisome proliferator-activated receptor delta/endothelial nitric oxide synthase signaling.
Xiao L; Dong JH; Teng X; Jin S; Xue HM; Liu SY; Guo Q; Shen W; Ni XC; Wu YM
J Hypertens; 2018 Mar; 36(3):651-665. PubMed ID: 29084084
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway.
Ji W; Liu S; Dai J; Yang T; Jiang X; Duan X; Wu Y
Chin Med J (Engl); 2014; 127(21):3751-7. PubMed ID: 25382331
[TBL] [Abstract][Full Text] [Related]
20. Regulation of vascular tone homeostasis by NO and H
Gheibi S; Jeddi S; Kashfi K; Ghasemi A
Biochem Pharmacol; 2018 Mar; 149():42-59. PubMed ID: 29330066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
